10 results
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Oral Hypoglycemics ... - PPAR gamma agonist ... AGENTS • GLP-1 agonists ... @AmyChung #Oral ... #Management #pharmacology
Summary of Non-Insulin Agents Used to Treat Diabetes

#Diabetes #Pharmacology #Comparison #Table #Medications #Noninsulin #Orals #Agents
Summary of Non-Insulin ... Used to Treat Diabetes ... #Diabetes #Pharmacology ... Medications #Noninsulin #Orals
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... GLP-1 receptor agonist ... in Type 1 Diabetes ... monitors in Type 1 Diabetes ... #Medications #pharmacology
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... medications for insulin ... There is an ORAL ... #Pharmacology #Dosing ... #Diabetes #DM2
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
the dose of an ACEi ... Continue ACEi or ... evidence-based pharmacologic ... #KDIGO #eGFR #Insulin ... #metformin #ACEi
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... glucose-dependent insulin ... #Pharmacology # ... Summary #DM2 #diabetes
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
-1 Agonist Dosing ... GLP1 agonist! ... GLP1 agonists are ... #semaglutide #Diabetes ... #Pharmacology #
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... • Increases insulin-mediated ... Most effective oral ... #Metformin #Pharmacology ... #Summary #DM2 #diabetes
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
FORMULATION: Powder for oral ... with CKD, HF, or diabetes ... ACE inhibitors, ... is taken as an oral ... #Hyperkalemia #Pharmacology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
neuroexam - Oral ... Insulin dependent ... ACEi/ARBs - Hold ... Diabetes regimen